Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common chronic
liver disease globally and is currently estimated to affect up to 38% of the global adult …

Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) pose a
significant threat to human health and cause a tremendous socioeconomic burden …

We aimed to determine the extent of multi-organ fat accumulation and fibro-inflammation in
individuals living with type 2 diabetes. We deeply phenotyped individuals with type 2 …

Although non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis are
increasingly recognised globally, 1 these terms were updated in June 2023 by an …

For end-stage liver disease in children, living donor liver transplantation (LDLT) is often the
important standard curative treatment. However, there is a lack of research on early recovery …

Background & Aims The aim of this study was to determine whether liver fibrosis is
associated with heart failure in a general population cohort, and if genetic polymorphisms …

Background Metabolic dysfunction-associated steatotic liver disease (MASLD) is a
predominant chronic liver condition globally and is strongly associated with obesity …

Background Life's essential'8 (LE8) is a newly updated cardiovascular health (CVH) metrics
from the American Heart Association, with close relevance to metabolism. Our objective is to …

Background: Type 2 diabetes mellitus (T2DM) is often complicated by steatotic liver disease,
cardiovascular disease (CVD), and extrahepatic cancer. We investigated whether FIB-4, an …

To the Editor, We read with great interest the study by Roca-Fernandez et al. which revealed
the Liver disease activity (measured by iron corrected T1-mapping (cT1)) was independently …